HOMATROPINE METHYLBROMIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for homatropine methylbromide and what is the scope of patent protection?
Homatropine methylbromide
is the generic ingredient in eight branded drugs marketed by Mission Pharma, Genus, Abhai Llc, Actavis Mid Atlantic, Ivax Sub Teva Pharms, Nostrum Labs Inc, Novel Labs Inc, Padagis Us, Sciegen Pharms Inc, Wockhardt Bio Ag, Halsey, Actavis Elizabeth, Avanthi Inc, and King Pharms, and is included in eighteen NDAs. Additional information is available in the individual branded drug profile pages.There are four drug master file entries for homatropine methylbromide.
Summary for HOMATROPINE METHYLBROMIDE
| US Patents: | 0 |
| Tradenames: | 8 |
| Applicants: | 14 |
| NDAs: | 18 |
| Drug Master File Entries: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 48 |
| DailyMed Link: | HOMATROPINE METHYLBROMIDE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for HOMATROPINE METHYLBROMIDE
US Patents and Regulatory Information for HOMATROPINE METHYLBROMIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Padagis Us | HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE | homatropine methylbromide; hydrocodone bitartrate | SYRUP;ORAL | 205731-001 | Feb 15, 2017 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Novel Labs Inc | HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE | homatropine methylbromide; hydrocodone bitartrate | TABLET;ORAL | 091528-001 | Apr 20, 2011 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Genus | HYCODAN | homatropine methylbromide; hydrocodone bitartrate | TABLET;ORAL | 005213-001 | Jul 26, 1988 | AA | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Genus | HYCODAN | homatropine methylbromide; hydrocodone bitartrate | SYRUP;ORAL | 005213-002 | Jul 26, 1988 | AA | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
